Keyphrases
Breast Cancer
100%
Loss of Heterozygosity
67%
RNA Interference
62%
Tumor
57%
Short Hairpin RNA (shRNA)
52%
MiR-424
40%
Breast Cancer Susceptibility Gene 1 (BRCA1)
39%
Breast Cancer Patients
39%
Plasma DNA
34%
P14ARF
34%
Breast Carcinoma
32%
Mammalian Cells
29%
Small Interfering RNA (siRNA)
26%
Allelic Loss
26%
Tumor DNA
26%
Breast Tumor
24%
MicroRNA
24%
Apoptosis
23%
Functional Genomics
23%
Primary Tumor
22%
Tumor Suppressor
22%
BRCA1 Gene
21%
Histone Deacetylase 6 (HDAC6)
20%
P16INK4a
20%
Loss Function
18%
Poor Prognosis
16%
Promoter Methylation
16%
Cancer Patients
16%
RNA Interference Screen
15%
Lymph Node Metastasis
15%
SgRNA Library
15%
Chemotherapy
14%
Overexpression
14%
Bladder Cancer
13%
Cell Differentiation
13%
Inflammatory Breast Cancer
13%
High-grade Malignancy
13%
EZH1
13%
Non-oncogene Addiction
13%
Drug-induced Apoptosis
13%
Circulating Tumor Cells
13%
Prostate Cancer
13%
Connectivity Map
13%
Enhancer of Zeste Homolog 2 (EZH2)
13%
BRCA2
13%
Map Data
13%
Human Breast Carcinoma
13%
BRCA mutation
13%
Mutational Status
13%
Transforming Growth Factor-β
13%
Biochemistry, Genetics and Molecular Biology
Loss of Heterozygosity
67%
BRCA1
61%
Small Hairpin RNA
57%
RNAI
56%
Cancer Cell
53%
MicroRNA
51%
Blood Plasma
51%
Genetics
38%
Carcinogenesis
33%
Messenger RNA
30%
Tumor Suppressor Protein
27%
P14arf
27%
Gene Mutation
27%
Microarrays
26%
Mammalian Cell
26%
Functional Genomics
24%
RNA
23%
Small Interfering RNA
23%
Promoter Region
23%
Genomics
22%
Stem Cell
22%
P53
17%
Colon
16%
Cellular Differentiation
16%
Oncogene
14%
Epidermal Growth Factor Receptor
14%
Microsatellite
14%
Downregulation
14%
Methylation
13%
HDAC6
13%
BRCA2
13%
P73
13%
Dynamics
13%
Virus Replication
13%
Cancer Growth Factor
13%
RNA Interference
12%
Anticancer
12%
Human Genome
11%
Overall Survival
11%
Involution
11%
Prevalence
11%
TNFAIP3
11%
BCL2L11
11%
Cell Death
11%
Progesterone Receptor
11%
Allele
11%
Upregulation
10%
Cancer Stem Cell
10%
Actin
9%
Disease Free Survival
9%
Medicine and Dentistry
Neoplasm
85%
Breast Cancer
77%
Breast Carcinoma
23%
Malignant Neoplasm
21%
Heterozygosity
20%
Histone Deacetylase 6
20%
BRCA1
20%
Cancer
20%
Cancer Cell
18%
RNAI
16%
Osteosarcoma
15%
Messenger RNA
14%
Functional Genomics
14%
Chemotherapy
13%
P73
13%
Lung Cancer
13%
Non Small Cell Lung Cancer
13%
Inflammatory Breast Cancer
13%
Oncogene Addiction
13%
Circulating Tumor Cell
13%
Protein P53
12%
Keratin 19
12%
Epidermal Growth Factor Receptor
12%
Epithelioma
11%
Lymph Node Metastasis
10%
Targeted Therapy
10%
Prognostic Factor
10%
Actin
10%
Exon
10%
Gene Mutation
9%
Neoadjuvant Chemotherapy
9%
Mastectomy
9%
Small Cell Lung Cancer
9%
Connective Tissue Cancer
9%
Carcinogenesis
8%
Cisplatin
8%
Tumor Suppressor Protein
8%
Radiosensitivity
8%
Adolescence
8%
Ricolinostat
8%
Overall Survival
7%
Small Interfering RNA
7%
Virus Replication
7%
Radiation Therapy
6%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Cancer Transplantation
6%
Hormone Receptor
6%
Limb
6%
Ovarian Tumor
6%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
6%